Skip to search formSkip to main contentSkip to account menu

Everolimus:MCnc:Pt:Bld:Qn

Known as: ????:????:???:??:???, Everolimus Sg-mCnc, Everolimus Bld-mCnc 
National Institutes of Health

Related topics

Related topics

4 relations
BloodUnit of Mass Concentrationeverolimuswhole blood

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Palbociclib-fulvestrant (PALBO-FUL) and everolimus -exemestane (EVE-EXE) for second line hormonal treatment (HT) of metastatic breast cancer (MBC) with lobular histology: A propensity score matched…
Abstract Background Recently, CDK4/6i proved to improve the efficacy of HT of pts affected by luminal MBC. However, the best… 
2017
2017
Erfolgreiche Everolimus-Therapie einer sporadischen Lymphangioleiomyomatose (sLAM) bei einer Patientin mit koinzidentem Mamma-Karzinom
2016
2016
BEZ235: When Promising Science Meets Clinical Reality
An article in a recent issue of The Oncologist reports the results of a phase I clinical trial of BEZ235 in patients with… 
2016
2016
Anti-tumor activity of selective inhibitor of nuclear export (SINE) compounds, is enhanced in non-Hodgkin lymphoma through combination with mTOR inhibitor and dexamethasone
2016
2016
Everolimus ist auch nach fünf Jahren noch wirksam
2014
2014
Analytical Performance of QMS Everolimus Assay on Ortho Vitros 5,1 FS Fusion Analyzer: Measuring Everolimus Trough Levels for Solid Organ Transplant Recipients
Background: Everolimus has recently been approved by Food and Drug Administration for graft maintenance in liver transplant… 
2014
2014
CLL-Therapie: Chancen und Risiken ausbalancieren
— Die nicht-interventionelle Studie CHANGE re ektiert laut Lothar Bergmann, Frankfurt/Main, den Routineeinsatz von Everolimus (A… 
2011
2011
Sequenztherapie beim metastasierten Nierenzellkarzinom in Deutschland 2010
ZusammenfassungHintergrundSeit 2006 wurden für die Behandlung des metastasierten Nierenzellkarzinoms (mNZK) 6 neue Substanzen in… 
2007
2007
Identification of Everolimus Metabolite Patterns in Trough Blood Samples of Kidney Transplant Patients
Everolimus is used as an immunosuppressant after organ transplantation. It is extensively metabolized, mainly by cytochrome… 
Review
2004
Review
2004
Rapamycin Analogs for Stent-Based Local Drug Delivery
Abstract.The inhibitory action of the sirolimus-like agent everolimus on smooth muscle cell proliferation, evidenced in animal… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)